Pernix Therapeutics Holdings, Inc.
(NASDAQ : PTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading PTX News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-7.91%166.039.9%$682.82m
VRXValeant Pharmaceuticals International, Inc.
-8.85%20.287.1%$590.12m
PRGOPerrigo Co. Plc
-4.44%90.974.0%$246.55m
ENDPEndo International Plc
-6.25%14.854.1%$131.38m
JAZZJazz Pharmaceuticals Plc
-4.90%137.902.7%$122.88m
ICPTIntercept Pharmaceuticals, Inc.
-7.35%142.9213.8%$89.19m
MNKMallinckrodt Plc
-4.85%55.8711.7%$88.70m
RLYPRelypsa, Inc.
-3.65%17.4333.0%$69.06m
HZNPHorizon Pharma plc
-6.82%16.259.7%$64.47m
UTHRUnited Therapeutics Corporation
-3.01%102.1119.5%$61.35m
MDCOMedicines Company
-3.71%33.2619.6%$47.24m
CTLTCatalent Inc
-3.76%22.774.1%$46.79m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-6.54%83.3112.2%$37.71m
ICLRICON Plc
0.31%67.623.3%$35.57m
ALRAlere Inc.
-2.14%41.674.7%$30.41m

Company Profile

Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. The firm distributes its products under the following brands: Treximet, Silenor, Zohydro ER with BeadTek, and Khedezla. The company was founded on March 9, 2010 and is headquartered in The Woodlands, TX.